These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 2460425)

  • 1. Simultaneous determination of testosterone, dihydrotestosterone and 5 alpha-androstan-3 alpha,-17 beta-diol by isotopic dilution mass spectrometry in plasma and prostatic tissue of patients affected by benign prostatic hyperplasia. Effects of 3-month treatment with a GnRH analog.
    Salerno R; Moneti G; Forti G; Magini A; Natali A; Saltutti C; Di Cello V; Costantini A; Serio M
    J Androl; 1988; 9(4):234-40. PubMed ID: 2460425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determination of testosterone and its tissue metabolites (DHT and 3 alpha-diol) in human plasma and prostatic tissue by isotopic dilution mass spectrometry.
    Moneti G; Giovannini MG; Guarna A; Forti G; Salerno R; Magini A; Serio M
    J Steroid Biochem; 1987; 27(1-3):53-9. PubMed ID: 2447389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measurement of testosterone and its 5-alfa-reduced metabolites in human prostatic tissue using isotope dilution mass spectrometry.
    Moneti G; Costantini A; Guarna A; Salerno R; Pazzagli M; Natali A; Goti A; Serio M
    J Steroid Biochem; 1986 Nov; 25(5B):765-72. PubMed ID: 3807362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Three-month treatment with a long-acting gonadotropin-releasing hormone agonist of patients with benign prostatic hyperplasia: effects on tissue androgen concentration, 5 alpha-reductase activity and androgen receptor content.
    Forti G; Salerno R; Moneti G; Zoppi S; Fiorelli G; Marinoni T; Natali A; Costantini A; Serio M; Martini L
    J Clin Endocrinol Metab; 1989 Feb; 68(2):461-8. PubMed ID: 2465302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum levels of follicle stimulating hormone, luteinizing hormone, prolactin, testosterone, 5 alpha-dihydrotestosterone, 5 alpha-androstane-3 alpha, 17 beta-diol, 5 alpha-androstane-3 beta, 17 beta-diol, and 17 beta-estradiol from male beagles with spontaneous or induced benign prostatic hyperplasia.
    Cochran RC; Ewing LL; Niswender GD
    Invest Urol; 1981 Nov; 19(3):142-7. PubMed ID: 6170603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationships between oestradiol-17 beta, testosterone, dihydrotestosterone and 5 alpha-androstane-3 alpha, 27 beta-diol in human benign hypertrophy and carcinoma of the prostate.
    Ghanadian R; Puah CM
    J Endocrinol; 1981 Feb; 88(2):255-62. PubMed ID: 6162906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating unconjugated 5 alpha-androstane-3 alpha, 17 beta-diol in elderly men and patients with prostatic tumours.
    Puah CM; Ghanadian R
    Age Ageing; 1983 Aug; 12(3):201-5. PubMed ID: 6194676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simultaneous measurements of testosterone and three 5 alpha-reduced androgens in the venous effluent of immature rat testes in situ.
    Foldesy RG; Leathem JH
    Steroids; 1980 Jun; 35(6):621-31. PubMed ID: 7404603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simultaneous determination of testosterone, 5alpha-androstan-17beta-ol-3-one, 5alpha-androstane-3alpha,17beta-diol and 5alpha-androstane-3beta,17beta-diol in plasma of adult male rabbits by radioimmunoassay(1).
    Schanbacher BD; Ewing LL
    Endocrinology; 1975 Oct; 97(4):787-92. PubMed ID: 1193006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased urinary 5 alpha-androstane-3 alpha,17 beta-diol glucuronide excretion in patients with benign prostatic hyperplasia.
    Wright F; Poizat R; Bongini M; Bozzolan F; Doukani A; Mauvais-Jarvis P
    J Clin Endocrinol Metab; 1985 Feb; 60(2):294-8. PubMed ID: 2578133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of a sequential extraction and liquid chromatography-tandem mass spectrometric method for determination of dihydrotestosterone, androstanediol and androstanediol-glucuronide in prostate tissues.
    Adomat HH; Bains OS; Lubieniecka JM; Gleave ME; Guns ES; Grigliatti TA; Reid RE; Riggs KW
    J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Aug; 902():84-95. PubMed ID: 22818945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of steroid concentrations in venous and arterial blood across the human testis. Unconjugated 5 alpha-androstane-3 beta, 17 beta-diol: an important androgen metabolite of the human testicular-epididymal unit.
    Tamm J; Volkwein U; Becker H; Klosterhalfen H
    J Steroid Biochem; 1982 Apr; 16(4):567-71. PubMed ID: 7087481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measurement of 5 alpha-androstane-3 alpha, 17 beta-diol in human spermatic venous plasma by mass-fragmentography.
    Moneti G; Pazzagli M; Fiorelli G; Serio M
    J Steroid Biochem; 1980 Jun; 13(6):623-7. PubMed ID: 7382501
    [No Abstract]   [Full Text] [Related]  

  • 14. Alteration in the metabolism of dihydrotestosterone in elderly men with prostate hyperplasia.
    Morimoto I; Edmiston A; Horton R
    J Clin Invest; 1980 Sep; 66(3):612-5. PubMed ID: 6156957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Origin of plasma androstanediol glucuronide in men.
    Moghissi E; Ablan F; Horton R
    J Clin Endocrinol Metab; 1984 Sep; 59(3):417-21. PubMed ID: 6746859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma concentrations of free 5 alpha-androstane-3 alpha, 17 beta-diol and related gonadal steroids during spontaneous and induced sexual maturation in the female rat.
    Cohen J; Doré C; Robaire B; Ruf KB
    Biol Reprod; 1984 Feb; 30(1):105-11. PubMed ID: 6696957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regional variations of insulin-like growth factor I (IGF-I), IGF-II, and receptor type I in benign prostatic hyperplasia tissue and their correlation with intraprostatic androgens.
    Monti S; Di Silverio F; Iraci R; Martini C; Lanzara S; Falasca P; Poggi M; Stigliano A; Sciarra F; Toscano V
    J Clin Endocrinol Metab; 2001 Apr; 86(4):1700-6. PubMed ID: 11297606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dihydrotestosterone concentration of beagle prostatic tissue: effect of age and hyperplasia.
    Ewing LL; Berry SJ; Higginbottom EG
    Endocrinology; 1983 Dec; 113(6):2004-9. PubMed ID: 6196180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of finasteride on serum levels of androstenedione, testosterone and their 5α-reduced metabolites in men at risk for prostate cancer.
    Stanczyk FZ; Azen CG; Pike MC
    J Steroid Biochem Mol Biol; 2013 Nov; 138():10-6. PubMed ID: 23474436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subnormal tissue 3 alpha-androstanediol and androsterone in prostatic hyperplasia.
    Meikle AW; Stringham JD; Olsen DC
    J Clin Endocrinol Metab; 1978 Oct; 47(4):909-13. PubMed ID: 95628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.